Baby Safety / Compounds / Hexabromocyclododecane (HBCDD)

Is Hexabromocyclododecane (HBCDD) safe for babies and kids?

High risk for kids

Infants face disproportionate exposure to Hexabromocyclododecane (HBCDD) through dust ingestion (hand-to-mouth behavior), breast milk transfer, and dermal contact with treated textiles in cribs and car seats.

What is hexabromocyclododecane (hbcdd)?

The IUPAC name is 1,3,5,7,9,11-hexabromocyclododecane.

Also known as: 1,3,5,7,9,11-hexabromocyclododecane, SAYTEX HBCD, RefChem:217126, PYROVATEX 3887.

IUPAC name
1,3,5,7,9,11-hexabromocyclododecane
CAS number
25637-99-4
Molecular formula
C12H18Br6
Molecular weight
641.7 g/mol
SMILES
C1C(CC(CC(CC(CC(CC1Br)Br)Br)Br)Br)Br
PubChem CID
33121

Risk for babies

High risk

Infants face disproportionate exposure to Hexabromocyclododecane (HBCDD) through dust ingestion (hand-to-mouth behavior), breast milk transfer, and dermal contact with treated textiles in cribs and car seats.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Elevated risk

Prenatal exposure to Hexabromocyclododecane (HBCDD) through dust inhalation and dietary intake can affect fetal thyroid function and neurodevelopment. Flame retardants accumulate in breast milk.

Suspected reproductive toxicant (GHS H361) or suspected endocrine disruptor. Precautionary approach warranted. Animal studies or limited human data suggest developmental toxicity potential.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

11 regulatory and scientific bodies have classified Hexabromocyclododecane (HBCDD). The classifications differ — that's the data.

AgencyYearClassificationNotes
UNEPPersistent Organic Pollutant (POP)
EPA CTX / GenetoxGenotoxicity: positive (Ames: positive, 3 positive / 6 negative reports)
EPA CTX / GenetoxGenotoxicity: positive (Ames: positive, 3 positive / 6 negative reports)
EPA CTX / Skin-EyeEye Irritation: Not classified (score: low)
EPA CTX / Skin-EyeSkin Irritation: Not classified (score: low)
EPA CTX / Skin-EyeSkin Sensitization: Not classified (score: low)
EPA CTX / Skin-Eyeskin irritation: in vivo: Studies Indicate No Significant Irritation (score: low)
EPA CTX / Skin-Eyeskin sensitisation: in vivo (non-LLNA): High Frequency of Sensitization (score: high)
EPA CTX / Skin-Eyeeye irritation: in vivo: Studies Indicate No Significant Irritation (score: low)
EPA CTX / Skin-Eyeskin sensitisation: in vivo (non-LLNA): Not likely to be sensitizing (score: low)
EPA CTX / Skin-Eyeskin sensitisation: in vivo (LLNA): Not likely to be sensitizing (score: low)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter hexabromocyclododecane (hbcdd)

  • Industrial FacilitiesManufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational EnvironmentsFactories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Hexabromocyclododecane (HBCDD):

  • Inherently flame-resistant materials (wool, modacrylic, Nomex)
    Trade-offs: Higher material cost. Limited color/texture options.
    Relative cost: 1.2-2×
  • Barrier fabric technology
    Trade-offs: Adds manufacturing step and cost
    Relative cost: 1.2-2×

Frequently asked questions

Is hexabromocyclododecane (hbcdd) safe for kids?

Infants face disproportionate exposure to Hexabromocyclododecane (HBCDD) through dust ingestion (hand-to-mouth behavior), breast milk transfer, and dermal contact with treated textiles in cribs and car seats.

What products contain hexabromocyclododecane (hbcdd)?

Hexabromocyclododecane (HBCDD) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to hexabromocyclododecane (hbcdd)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about hexabromocyclododecane (hbcdd)?

Hexabromocyclododecane (HBCDD) has been classified by 11 agencies including UNEP, EPA CTX / Genetox, EPA CTX / Genetox, EPA CTX / Skin-Eye, EPA CTX / Skin-Eye, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Hexabromocyclododecane (HBCDD) in the baby app

Look up products containing hexabromocyclododecane (hbcdd), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (2)

  1. Stockholm Convention: Hexabromocyclododecane (HBCDD) — Listed under Annex A (Elimination), COP-6 Decision SC-6/13, Global POP Assessment, PBT Properties, Long-Range Transport, Arctic Contamination (2013) (2013) — regulatory
  2. ECHA: Hexabromocyclododecane (HBCDD) — PBT/vPvB Assessment, SVHC Identification, REACH Restriction Annex XVII, Thyroid Disruption, Breast Milk Monitoring (2010) (2010) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →